Advertisement
Share

Drug OKd for brain disorder

From Times Wire Services

The first U.S. treatment to reduce involuntary movements caused by Huntington’s disease, a genetic brain disorder, was approved by the Food and Drug Administration.

The FDA cleared Xenazine, a tablet made by closely held Prestwick Pharmaceuticals Inc.


Advertisement